When a tumor cohort from 122 NB patients was analyzed, GALNT9 expression was associated with high overall survival, independently of the standard risk-stratification covariates, and it was significantly associated with disease-free survival for patients currently classified as low risk (57). This evidence concerns the gene GALNT9 and neoplasm.